ArticleCancer immunology, immunotherapy : CII2017

A new peptide vaccine OCV-501: in vitro pharmacology and phase 1 study in patients with acute myeloid leukemia.

Yukio Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.